These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30342794)

  • 1. Graves' disease: Introduction, epidemiology, endogenous and environmental pathogenic factors.
    Wémeau JL; Klein M; Sadoul JL; Briet C; Vélayoudom-Céphise FL
    Ann Endocrinol (Paris); 2018 Dec; 79(6):599-607. PubMed ID: 30342794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New perspectives for the diagnosis and prognosis of Graves' disease].
    Tatulashvili S; Baudry C; Sadoul JL; Bihan H
    Ann Endocrinol (Paris); 2018 Sep; 79 Suppl 1():S31-S39. PubMed ID: 30213303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center.
    Tanda ML; Piantanida E; Liparulo L; Veronesi G; Lai A; Sassi L; Pariani N; Gallo D; Azzolini C; Ferrario M; Bartalena L
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1443-9. PubMed ID: 23408569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graves' disease: Epidemiology, genetic and environmental risk factors and viruses.
    Antonelli A; Ferrari SM; Ragusa F; Elia G; Paparo SR; Ruffilli I; Patrizio A; Giusti C; Gonnella D; Cristaudo A; Foddis R; Shoenfeld Y; Fallahi P
    Best Pract Res Clin Endocrinol Metab; 2020 Jan; 34(1):101387. PubMed ID: 32107168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.
    Villanueva R; Inzerillo AM; Tomer Y; Barbesino G; Meltzer M; Concepcion ES; Greenberg DA; MacLaren N; Sun ZS; Zhang DM; Tucci S; Davies TF
    Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Graves' disease].
    Illouz F; Rodien P
    Rev Prat; 2014 Jun; 64(6):828-34. PubMed ID: 25090772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graves' disease in children.
    Léger J; Oliver I; Rodrigue D; Lambert AS; Coutant R
    Ann Endocrinol (Paris); 2018 Dec; 79(6):647-655. PubMed ID: 30180972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and classification of Graves' disease.
    Menconi F; Marcocci C; Marinò M
    Autoimmun Rev; 2014; 13(4-5):398-402. PubMed ID: 24424182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
    Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
    Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of adult Graves' disease.
    Corvilain B; Hamy A; Brunaud L; Borson-Chazot F; Orgiazzi J; Bensalem Hachmi L; Semrouni M; Rodien P; Lussey-Lepoutre C
    Ann Endocrinol (Paris); 2018 Dec; 79(6):618-635. PubMed ID: 30193753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of hyperthyroidism due to Graves' disease: frequently asked questions and answers (if any).
    Bartalena L; Chiovato L; Vitti P
    J Endocrinol Invest; 2016 Oct; 39(10):1105-14. PubMed ID: 27319009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiopathogenesis of Graves' disease.
    Karasek M; Lewinski A
    Neuro Endocrinol Lett; 2003; 24(3-4):161-6. PubMed ID: 14523350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Graves' orbitopathy].
    Balázs C
    Orv Hetil; 2006 Jun; 147(22):1011-7. PubMed ID: 16913090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
    Pawlak-Adamska E; Frydecka I; Bolanowski M; Tomkiewicz A; Jonkisz A; Karabon L; Partyka A; Nowak O; Szalinski M; Daroszewski J
    Endocrine; 2017 Jan; 55(1):186-199. PubMed ID: 27638540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemiology of Graves' disease: evidence of a genetic and an environmental contribution.
    Hemminki K; Li X; Sundquist J; Sundquist K
    J Autoimmun; 2010 May; 34(3):J307-13. PubMed ID: 20056533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking and risk of Graves' disease.
    Prummel MF; Wiersinga WM
    JAMA; 1993 Jan; 269(4):479-82. PubMed ID: 8419666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of genetic and non-genetic factors in the etiology of Graves' disease.
    Marinò M; Latrofa F; Menconi F; Chiovato L; Vitti P
    J Endocrinol Invest; 2015 Mar; 38(3):283-94. PubMed ID: 25421156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graves' disease in subjects with type 1 diabetes mellitus: a prevalence study in western Sicily (Italy).
    Greco D; Pisciotta M; Gambina F; Maggio F
    Prim Care Diabetes; 2011 Dec; 5(4):241-4. PubMed ID: 21704580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking and other lifestyle factors and the risk of Graves' hyperthyroidism.
    Holm IA; Manson JE; Michels KB; Alexander EK; Willett WC; Utiger RD
    Arch Intern Med; 2005 Jul; 165(14):1606-11. PubMed ID: 16043678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic and environmental factors in Graves disease. A review].
    Brix TH; Kyvik KO; Hegedüs L
    Ugeskr Laeger; 1998 Jan; 160(5):616-21. PubMed ID: 9470466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.